Skip to content

Assessment of response to antacids in children with Eosinophilic Esophagitis

Evaluation of response to proton pump inhibitors in pediatric patients with Eosinophilic Esophagitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-2ntbth9
Enrollment
Unknown
Registered
2024-01-29
Start date
2021-05-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Esophagitis

Interventions

Clinical, prospective, open trial study. A total of 27 patients with the diagnosis of Eosinophilic Esophigitis were included. After the diagnosis, All of the patients received treatment with proton pu

Sponsors

Hospital Santa Casa de Misericórdia de Porto Alegre
Lead Sponsor
Hospital Santa Casa de Misericórdia de Porto Alegre
Collaborator

Eligibility

Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children and Adolescents aged 1month to 18 years who were referred to the pediatric endoscopy unit were included. Patients were included when they met the diagnosis criteria for Eosinophilic esophagitis (presenting at least one symptom of esophageal dysfunction; esophageal biopsy with more than 15 eosinophil per high power field) and absence of gastric and duodenal eosinophilia. 4 to 6 biopsies were randomly obtained from the distal and middle esophagus. Biopsies specimens were also obtained from the antrum and duodenum to exclude gastritis and eosinophilic gastroenteritis

Exclusion criteria

Exclusion criteria: Children were excluded if they had received prior and recent (up to 1 month before the endoscopy) treatment with proton pump inhibitor; corticosteroids or elimination diet; or if they presented duodenal or gastric eosinophilia or viral, fungal or caustic esophagitis

Design outcomes

Primary

MeasureTime frame
It is expected to find a therapeutic response in pediatric patients with eosinophilic esophagitis who received proton pump inhibitor medication

Secondary

MeasureTime frame
It is expected to find demographic associations in pediatric patients with eosinophilic esophagitis that received proton pump inhibitors medication. Its is expected to find clinical, endoscopic and histological associations in pediatric patients with eosinophilic esophagitis who received proton pump inhibitor medication

Countries

Brazil

Contacts

Public ContactLuiza Salgado Nader

Hospital Santa Casa de Misericórdia de Porto Alegre

luizasnader@gmail.com+555132148000

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 6, 2026